{"database": "lobbying", "table": "lobbying_activities", "rows": [[1974200, "0856eb7e-4e5e-479d-bc24-0d18cdbac162", "Q1", "THE ADVOCACY GROUP", 261, "EMERGENT BIOSOLUTIONS", 2017, "first_quarter", "DIS", "FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures.\nProvisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.", "Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2017-04-20T16:24:21.917000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1974200"], "units": {}, "query_ms": 20.938053028658032, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}